Cipher Pharmaceuticals Inc.
CPHR
CPHR was delisted on the 8th of December, 2016.
19 hedge funds and large institutions have $40.2M invested in Cipher Pharmaceuticals Inc. in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 4 closing their positions.
10% more capital invested
Capital invested by funds: $36.8M → $40.2M (+$3.49M)
10% less funds holding
Funds holding: 21 → 19 (-2)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Taylor Asset Management
Toronto,
Ontario, Canada
|
+$2.45M |
| 2 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
+$673K |
| 3 |
IIM
Intact Investment Management
Montreal,
Quebec, Canada
|
+$36.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.34K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MBI
Montrusco Bolton Investments
Montreal,
Quebec, Canada
|
-$199K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$195K |
| 3 |
Morgan Stanley
New York
|
-$127K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$108K |
| 5 |
Goldman Sachs
New York
|
-$91K |
CPHR Hedge Fund Activity: Q1 2016 in Review
19 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Cipher Pharmaceuticals Inc. (CPHR) for Q1 2016, worth a combined $40.2M — up 9.5% from $36.8M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CPHR and 2 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 4 added.
The largest buyer was Taylor Asset Management, adding an estimated $2.45M. The largest seller was Montrusco Bolton Investments, cutting an estimated $199K.
- 19 institutional investors held Cipher Pharmaceuticals Inc. (CPHR) as of Q1 2016, down from 21 in Q4 2015.
- Funds reported $40.2M of Cipher Pharmaceuticals Inc. stock for Q1 2016, up 9.5% quarter-over-quarter.
- 2 funds opened new Cipher Pharmaceuticals Inc. positions in Q1 2016 and 4 closed out, a net change of -2 holders.
- The largest Cipher Pharmaceuticals Inc. buyer in Q1 2016 was Taylor Asset Management, an estimated $2.45M added.
- The largest Cipher Pharmaceuticals Inc. seller in Q1 2016 was Montrusco Bolton Investments, an estimated $199K sold.
Based on aggregated 13F filings for Q1 2016.